| Literature DB >> 30888525 |
Wintai Kamolsukyeunyong1, Siriphat Ruengphayak2, Pantharika Chumwong1, Lucia Kusumawati1, Ekawat Chaichoompu2,3, Watchareewan Jamboonsri1, Chatree Saensuk2, Kunyakarn Phoonsiri2, Theerayut Toojinda1,4, Apichart Vanavichit5,6,7.
Abstract
BACKGROUND: The development of rice varieties with broad-spectrum resistance to insect pests is the most promising approach for controlling a fast evolving insect pest such as the brown planthopper (BPH). To cope with rapid evolution, discovering new sources of broad-spectrum resistance genes is the ultimate goal.Entities:
Keywords: BPH resistance gene; Brown planthopper; Double digest restriction site-associated DNA sequencing; Fast-neutron mutagenesis; Haplotype pattern; QTL-seq; Single-nucleotide polymorphism
Year: 2019 PMID: 30888525 PMCID: PMC6424995 DOI: 10.1186/s12284-019-0274-1
Source DB: PubMed Journal: Rice (N Y) ISSN: 1939-8425 Impact factor: 4.783
Fig. 1Frequency distribution of average AUC of damage scores on BILs from 6 BPH populations
Fig. 2The genome-wide scanning of average ΔSNP-indexes graphs plotted along the rice genome. a The individual extreme BILs, b the pooled extreme BILs. c Candidate QTL locations were identified on rice chromosome 4 with statistical confidence intervals under the null hypothesis of no QTL (P < 0.05). d Linkage disequilibrium (LD) plot for SNPs in the QBPH4.1 and QBPH4.2 regions. The D’ values (normalized linkage disequilibrium scores) for SNPs covered the LD blocks were shown. The SNPs were genotyped in the BIL population by KASP genotyping
List of SNP identified on the QBPH4.1 sliding window (5.78–7.78 Mb) on chromosome 4. SI = SNP index; QS = QBPHS; QR = QBPHR; IndS = BPHS; IndR = BPHR; AAC = amino acid change; (−) = synonymous variant; (+) = missense variant or stop codon
| Position | LOC identifier | gene product name | KASP-SNP marker | SNP S/R | SI in QS | SI in QR | SI in IndS | SI in IndR | SNP pos / CDS length | SNP effect | AAC | AAC position/protein length |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5,806,676 | LOC_Os04g10680 | zinc finger, C3HC4 type domain containing protein | T/C | 0.0 | 100.0 | 0.0 | 100.0 | 2071/3059 | – | |||
| 5,867,185 | LOC_Os04g10800 | inorganic phosphate transporter | A/G | NA | NA | 0.0 | 100.0 | 534/1527 | – | |||
| 5,867,219 | LOC_Os04g10800 | inorganic phosphate transporter | R04005867219 | G/C | 0.0 | 85.0 | 0.0 | 100.0 | 568/1527 | + | A > P | 190/508 |
| 5,867,260 | LOC_Os04g10800 | inorganic phosphate transporter | T/C | 0.9 | 82.9 | 0.0 | 100.0 | 609/1527 | – | |||
| 5,867,320 | LOC_Os04g10800 | inorganic phosphate transporter | T/G | 0.0 | 80.0 | 0.0 | 100.0 | 669/1527 | – | |||
| 6,069,830 | LOC_Os04g11165 | gamma-thionin family domain containing protein | R04006069830 | G/T | NA | NA | 100.0 | 0.0 | 201/216 | + | stop codon | 67/71 |
| 6,069,877 | LOC_Os04g11165 | gamma-thionin family domain containing protein | R04006069877 | A/G | 0.0 | 81.0 | 0.0 | 81.0 | 154/216 | + | C > R | 52/71 |
| 6,069,900 | LOC_Os04g11165 | gamma-thionin family domain containing protein | R04006069900 | A/G | 0.0 | 81.0 | 0.0 | 81.0 | 131/216 | + | I > T | 44/71 |
| 6,263,052 | LOC_Os04g11450 | OsFBX118 - F-box domain containing protein | A/G | 8.2 | 91.7 | 0.0 | 88.9 | 1011/1480 | – | |||
| 6,263,057 | LOC_Os04g11450 | OsFBX118 - F-box domain containing protein | R04006263057 | G/C | 91.8 | 4.0 | 100.0 | 0.0 | 922/1203 | + | Q > E | 308/400 |
| 6,263,087 | LOC_Os04g11450 | OsFBX118 - F-box domain containing protein | R04006263087 | A/T | 8.2 | 92.0 | 0.0 | 90.0 | 892/1203 | + | Y > N | 298/400 |
| 6,263,168 | LOC_Os04g11450 | OsFBX118 - F-box domain containing protein | R04006263168 | C/G | 38.8 | 96.9 | 0.0 | 96.8 | 811/1203 | + | V > L | 271/400 |
| 6,263,172 | LOC_Os04g11450 | OsFBX118 - F-box domain containing protein | T/A | 36.7 | 96.5 | 0.0 | 96.0 | 891/1480 | – | |||
| 6,388,017 | LOC_Os04g11660 | OsFBX119 - F-box domain containing protein | R04006388017 | C/A | 16.7 | 97.7 | 16.7 | 97.7 | 837/1137 | + | K > N | 279/378 |
| 6,388,020 | LOC_Os04g11660 | OsFBX119 - F-box domain containing protein | A/G | 16.7 | 97.7 | 16.7 | 97.7 | 916/1766 | – | |||
| 6,388,038 | LOC_Os04g11660 | OsFBX119 - F-box domain containing protein | G/T | 13.5 | 100.0 | 0.0 | 100.0 | 898/1766 | – | |||
| 6,388,095 | LOC_Os04g11660 | OsFBX119 - F-box domain containing protein | R04006388095 | G/C | 10.8 | 100.0 | 0.0 | 100.0 | 759/1137 | + | D > E | 253/378 |
| 6,451,402 | LOC_Os04g11780 | resistance protein LR10 | C/A | 0.0 | 100.0 | 0.0 | 100.0 | 1110/1998 | – | |||
| 6,451,404 | LOC_Os04g11780 | resistance protein LR10 | R04006451404 | T/C | 0.0 | 100.0 | 0.0 | 100.0 | 1112/1998 | + | I > T | 371/665 |
| 6,451,423 | LOC_Os04g11780 | resistance protein LR10 | A/T | 0.0 | 100.0 | 0.0 | 100.0 | 1131/1998 | + | E > D | 377/665 | |
| 6,451,424 | LOC_Os04g11780 | resistance protein LR10 | R04006451424 | C/A | 0.0 | 100.0 | 0.0 | 100.0 | 1132/1998 | + | L > M | 378/665 |
| 6,451,469 | LOC_Os04g11780 | resistance protein LR10 | R04006451469 | G/A | 2.9 | 100.0 | 2.9 | 100.0 | 1177/1998 | + | V > I | 393/665 |
| 6,451,485 | LOC_Os04g11780 | resistance protein LR10 | R04006451485 | A/G | 2.9 | 100.0 | 2.9 | 100.0 | 1193/1998 | + | K > R | 398/665 |
| 6,451,495 | LOC_Os04g11780 | resistance protein LR10 | R04006451495 | T/G | 2.9 | 100.0 | 2.9 | 100.0 | 1203/1998 | + | D > E | 401/665 |
| 6,455,216 | LOC_Os04g11790 | OsFBX120 - F-box domain containing protein | T/C | 25.0 | 98.3 | 0.0 | 95.8 | 827/1461 | – | |||
| 6,455,225 | LOC_Os04g11790 | OsFBX120 - F-box domain containing protein | C/T | 75.0 | 1.6 | 100.0 | 4.2 | 818/1461 | – | |||
| 6,593,508 | LOC_Os04g12010 | glycosyltransferase | G/T | 24.3 | 96.6 | 0.0 | 94.5 | 1455/1774 | – | |||
| 6,593,541 | LOC_Os04g12010 | glycosyltransferase | G/A | 22.2 | 96.7 | 0.0 | 94.8 | 1422/1774 | – | |||
| 6,659,796 | LOC_Os04g12110 | expressed protein | C/A | NA | NA | 100.0 | 0.0 | 1818/1839 | – | |||
| 6,659,820 | LOC_Os04g12110 | expressed protein | G/A | 75.9 | 0.0 | 75.9 | 0.0 | 1794/1839 | – | |||
| 6,659,826 | LOC_Os04g12110 | expressed protein | A/G | 100.0 | 11.1 | 100.0 | 11.1 | 1788/1839 | – | |||
| 6,659,838 | LOC_Os04g12110 | expressed protein | A/G | 100.0 | 11.1 | 100.0 | 11.1 | 1776/1839 | – | |||
| 6,659,844 | LOC_Os04g12110 | expressed protein | R04006659844 | C/A | 75.9 | 0.0 | 75.9 | 0.0 | 1770/1839 | + | R > S | 590/612 |
| 6,659,845 | LOC_Os04g12110 | expressed protein | R04006659845 | C/G | 75.9 | 0.0 | 75.9 | 0.0 | 1769/1839 | + | R > T | 590/612 |
| 6,659,847 | LOC_Os04g12110 | expressed protein | G/T | 75.5 | 0.0 | 75.5 | 0.0 | 1767/1839 | – | |||
| 6,659,872 | LOC_Os04g12110 | expressed protein | R04006659872 | C/T | 88.6 | 5.3 | 100.0 | 7.4 | 1742/1839 | + | C > Y | 581/612 |
| 6,659,873 | LOC_Os04g12110 | expressed protein | R04006659873 | A/T | 88.6 | 5.3 | 100.0 | 7.4 | 1741/1839 | + | C > S | 581/612 |
| 6,659,874 | LOC_Os04g12110 | expressed protein | A/G | 88.6 | 5.3 | 100.0 | 7.4 | 1740/1839 | – | |||
| 6,659,877 | LOC_Os04g12110 | expressed protein | A/C | 88.6 | 5.3 | 100.0 | 7.4 | 1737/1839 | – | |||
| 6,659,884 | LOC_Os04g12110 | expressed protein | R04006659884 | G/C | 89.1 | 5.3 | 100.0 | 7.4 | 1730/1839 | + | S > C | 577/612 |
| 6,659,915 | LOC_Os04g12110 | expressed protein | R04006659915 | T/C | 88.9 | 5.4 | 100.0 | 7.4 | 1699/1839 | + | I > V | 567/612 |
| 6,925,203 | LOC_Os04g12530 | amino acid transporter family protein | R04006925203 | T/G | 0.0 | 80.0 | 0.0 | 80.0 | 404/612 | + | D > A | 135/203 |
| 6,925,208 | LOC_Os04g12530 | amino acid transporter family protein | C/G | NA | NA | 0.0 | 75.0 | 399/612 | – | |||
| 6,925,211 | LOC_Os04g12530 | amino acid transporter family protein | C/G | NA | NA | 0.0 | 71.4 | 396/612 | – | |||
| 6,968,050 | LOC_Os04g12580 | receptor-like protein kinase (OsLecRK3) | OsLecRK3-SNP | A/G | NA | NA | 0.0 | 100.0 | 990/2346 | – | ||
| 6,977,171 | LOC_Os04g12600 | receptor-like protein kinase | G/A | 96.6 | 0.0 | 96.6 | 0.0 | 2079/2415 | – | |||
| 6,978,761 | LOC_Os04g12600 | receptor-like protein kinase | C/T | 100.0 | 0.0 | 100.0 | 0.0 | 489/2415 | – |
List of SNP identified on the QBPH4.2 sliding window (15.22–17.22 Mb) on chromosome 4. SI = SNP index; QS = QBPHS; QR = QBPHR; IndS = BPHS; IndR = BPHR; AAC = amino acid change; (−) = synonymous variant; (+) = missense variant or stop codon
| Position | LOC identifier | gene product name | KASP-SNP marker | SNP S/R | SI in QS | SI in QR | SI in IndS | SI in IndR | SNP pos / CDS length | SNP effect | AAC | AAC position/protein length |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15,893,411 | LOC_Os04g26870 | oxidoreductase | A/G | 37.8 | 100.0 | 0.0 | 100.0 | 906/1053 | – | |||
| 15,893,519 | LOC_Os04g26870 | oxidoreductase | C/T | NA | NA | 0.0 | 71.4 | 1014/1053 | – | |||
| 15,916,097 | LOC_Os04g26910 | oxidoreductase | T/C | 40.8 | 97.3 | 0.0 | 100.0 | 255/1056 | – | |||
| 15,916,138 | LOC_Os04g26910 | oxidoreductase | R04015916138 | A/C | 42.6 | 97.1 | 0.0 | 100.0 | 410/1470 | + | E > A | 99/351 |
| 15,916,153 | LOC_Os04g26910 | oxidoreductase | R04015916153 | A/G | 46.2 | 1.7 | 100.0 | 0.0 | 425/1470 | + | D > G | 104/351 |
| 16,044,907 | LOC_Os04g27096 | expressed protein | G/A | 0.0 | 95.2 | 0.0 | 94.1 | 418/687 | – | |||
| 16,214,690 | LOC_Os04g27430 | sesquiterpene synthase2 | OsSTPS2_21bp_del | −/TTTATGCCTCTGGTGTGACCA | 0.0 | 100.0 | 0.0 | 100.0 | 477/1416 | + | 7-aa-ins | 313/472 |
| 16,380,993 | LOC_Os04g27720 | terpene synthase | R04016380993 | A/C | 100.0 | 1.7 | 100.0 | 1.7 | 1161/1518 | + | S > R | 387/505 |
| 16,582,690 | LOC_Os04g28090 | MYB family transcription factor | C/T | 0.0 | 100.0 | 0.0 | 100.0 | 621/2919 | – | |||
| 16,586,281 | LOC_Os04g28090 | MYB family transcription factor | G/A | 100.0 | 7.7 | 100.0 | 7.7 | 2337/2919 | – | |||
| 16,627,505 | LOC_Os04g28150 | expressed protein | R04016627505 | C/G | 0.0 | 100.0 | 0.0 | 100.0 | 795/867 | + | D > E | 265/288 |
| 16,632,510 | LOC_Os04g28160 | response regulator receiver domain containing protein | T/C | 0.0 | 100.0 | 0.0 | 100.0 | 705/1143 | – | |||
| 16,672,214 | LOC_Os04g28210 | verticillium wilt disease resistance protein | R04016672214 | T/G | 21.9 | 96.2 | 0.0 | 88.9 | 295/3775 | + | D > A | 85/1034 |
| 16,713,777 | LOC_Os04g28270 | expressed protein | C/T | 1.2 | 97.2 | 0.0 | 98.8 | 285/438 | – | |||
| 16,732,393 | LOC_Os04g28280 | BEE 3 | T/C | 0.0 | 97.0 | 0.0 | 97.0 | 792/792 | – | 264/263 |
Association between markers and BPH resistance in BIL population based on linear regression analysis. Five BPH populations were used, KPP, PSL, UBN, TPY, and HTL. R2 indicating the proportion of the phenotypic variation contributed by each marker
| BPH | Sliding window | Marker | LOC no. | Chr | P-value | R2 | KDML105 allele | RH allele | ||
|---|---|---|---|---|---|---|---|---|---|---|
| count | AUC means | count | AUC means | |||||||
| HTL | QBPH4.1 | OsLecRK3_SNP | LOC_Os04g12580 | 4 | < 0.001** | 29.6 | 16 | 29.812 | 76 | 20.474 |
| R04006263057 | LOC_Os04g11450 | 4 | 0.008** | 9.6 | 18 | 22.333 | 64 | 21.375 | ||
| R04006263168 | LOC_Os04h11450 | 4 | 0.048* | 5.4 | 16 | 21.5 | 65 | 21.462 | ||
| QBPH4.2 | OsSTPS2_21bp_indel | LOC_Os04g27430 | 4 | < 0.001** | 17.2 | 11 | 28.909 | 77 | 20.87 | |
| R04015916153 | LOC_Os04g26910 | 4 | 0.005** | 9.2 | 20 | 21.9 | 62 | 21.177 | ||
| R04016672214 | LOC_Os04g28210 | 4 | 0.014* | 7.1 | 18 | 23.167 | 68 | 22.456 | ||
| Chr6:0.03–2.03 Mb | BPH32-SNP | LOC_Os06g03240 | 6 | 0.001** | 12.4 | 19 | 25.61 | 72 | 20.59 | |
| KPP | QBPH4.1 | OsLecRK3_SNP | LOC_Os04g12580 | 4 | < 0.001** | 54.9 | 16 | 23 | 76 | 13.447 |
| R04006451469 | LOC_Os04g11780 | 4 | 0.047* | 4.5 | 17 | 14.412 | 66 | 14.773 | ||
| R04006659915 | LOC_Os04g12110 | 4 | 0.026* | 6.9 | 10 | 15.7 | 72 | 14.944 | ||
| QBPH4.2 | OsSTPS2_21bp_indel | LOC_Os04g27430 | 4 | < 0.001** | 49.8 | 11 | 14.182 | 77 | 13.649 | |
| Chr6:0.03–2.03 Mb | Bph32-SNP | LOC_Os06g03240 | 6 | 0.793 | na | na | na | na | na | |
| PSL | QBPH4.1 | OsLecRK3-SNP | LOC_Os04g12580 | 4 | < 0.001** | 21.8 | 16 | 28.5 | 76 | 21.118 |
| QBPH4.2 | OsSTPS2_21bp_indel | LOC_Os04g27430 | 4 | < 0.001** | 13.9 | 11 | 27.273 | 77 | 21.377 | |
| R04016380993 | LOC_Os04g27720 | 4 | 0.011* | 7.6 | 24 | 21.75 | 65 | 23.077 | ||
| Chr6:0.03–2.03 Mb | BPH32-SNP | LOC_Os06g03240 | 6 | 0.436 | na | na | na | na | na | |
| TPY | QBPH4.1 | OsLecRK3-SNP | LOC_Os04g12580 | 4 | < 0.001** | 16.4 | 16 | 24.188 | 76 | 19.316 |
| QBPH4.2 | OsSTPS2_21bp_indel | LOC_Os04g27430 | 4 | 0.007** | 8.5 | 11 | 23.636 | 77 | 19.532 | |
| Chr6:0.03–2.03 Mb | BPH32-SNP | LOC_Os06g03240 | 6 | 0.966 | na | na | na | na | na | |
| UBN | QBPH4.1 | OsLecRK3-SNP | LOC_Os04g12580 | 4 | < 0.001** | 43.7 | 16 | 27.25 | 76 | 16.908 |
| R04006659915 | LOC_Os04g12110 | 4 | 0.033* | 6.3 | 10 | 19.7 | 72 | 18.556 | ||
| QBPH4.2 | OsSTPS2_21bp_indel | LOC_Os04g27430 | 4 | < 0.001** | 29.8 | 11 | 26.636 | 77 | 17.26 | |
| R04015916153 | LOC_Os04g26910 | 4 | 0.033* | 5.3 | 20 | 17.6 | 62 | 18.339 | ||
| R04016380993 | LOC_Os04g27720 | 4 | 0.043* | 4.7 | 24 | 17.542 | 65 | 19.462 | ||
| Chr6:0.03–2.03 Mb | BPH32-SNP | LOC_Os06g03240 | 6 | 0.059 | na | na | na | na | na | |
*Significant at P = 0.05
**Significant at P = 0.001
Genotyping data at two loci used for reverse screening of selected mutant lines and BPH damage AUC tests using 3 BPH populations. The “Ins” indicated insertion allele while “Del” indicated deletion allele of the OsSTPS2-21 bp-indel marker. Letter a, b, c, d, e, f, g indicated similarity of the traits in multiple comparison tests
| QBPH4.1 | QBPH4.2 | BPH damage AUC | |||
|---|---|---|---|---|---|
| OsLecRK3-SNP | OsSTPS2-21 bp-indel | CNT | TPY | UBN | |
| RH | G | Ins | 6a | 7a | 16a |
| JHN4 | G | Ins | 10a | 8a | 17a |
| JHN12005 | G | Ins | 13a | 11.33ab | 44c |
| JHN19525 | G | Ins | 30b | 13.5ab | 41c |
| JHN09962 | G | Ins | 45c | 22.5b | 27.5ab |
| JHN19874 | G | Ins | 46c | 43cd | 57.67de |
| JHN07766 | G | Ins | 47c | 40c | 61de |
| JHNMT2 | A | Ins | 50c | 42cd | 56.33de |
| JHN11183 | G | Del | 51c | 49cdef | 39c |
| JHNMT1 | A | Ins | 51c | 38.33c | 48.67d |
| JHN05678 | G | Ins | 51c | 47cde | 63e |
| JHN19572 | G | Ins | 52c | 52.33defg | 57.67de |
| JHN21689 | G | Ins | 52c | 59efg | 61.67e |
| JHN16065 | A | Ins | 54c | 60.33g | 59de |
| JHN02313 | G | Del | 54c | 61.67g | 60.33de |
| JHN15723 | A | Del | 54c | 63g | 60.33de |
| JHN18131 | A | Del | 54c | 59.33fg | 60.33de |
| JHN | A | Del | 54c | 63g | 61.67e |
| JHN19671 | A | Ins | 54c | 63g | 61.67e |
| JHN12686 | A | Ins | 54c | 63g | 63e |
| JHN17767 | A | Del | 54c | 60.33g | 63e |
| JHN19577 | G | Ins | 54c | 63g | 63e |
| JHN19578 | G | Ins | 54c | 54defg | 63de |
| JHN21688 | G | Del | 54c | 63g | 63e |
Fig. 3Amino acids analysis of OsLecRK1–3 in JHN WT, mutant lines and BPH-resistant variety Rathu Heenati (RH). Polymorphic sites are positioned relative to the first amino acid in RH. The sequence information for OsLecRK1–3 of RH are from the GenBank database (accession no. AIE56222, AIE56230, and AIE56238 respectively). Amino acid changes were highlighted in yellow, and amino acid that JHN WT differed from RH were highlighted in green. The amino acid positions that are corresponding to KASP-SNP markers used for haplotype pattern analysis of mutant lines were highlighted by lighted-gray
Association between candidate genes with BPH resistance in mutant lines based on HPs using linear regression and ANOVA. Three BPH populations were used in this study, i.e., CNT, TPY, and UBN. KASP-SNP markers using for HP specification were indicated for each gene
| BPH | Gene | PVE (%) | Significant HPs | Haplotype patterns | Mean AUC | count | Damage reducing ratio (DRR) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CNT | F-box 119 | 0.039* | 24.8 | 2 | KASP-SNP | R04006388017 | R04006388095 | 0.688 | |||||
| mutant | Hetero | G | 36.667 | 3 | |||||||||
| wt | C | G | 53.25 | 12 | |||||||||
| BPH9_Chr12 | 0.005** | 40.6 | 2 | KASP-SNP | R1222886067 | R1222886105 | 0.535 | ||||||
| mutant | G | T | 28.333 | 3 | |||||||||
| wt | A | G | 52.923 | 13 | |||||||||
| TPY | inorganic phosphate transporter | 0.047* | 13.5 | 1 (WT) | KASP-SNP | R04005867219 | 1.373 | ||||||
| mutant | G | 58.951 | 7 | ||||||||||
| wt | C | 42.937 | 16 | ||||||||||
| gamma thionin protein | 0.012* | 38.2 | 2 | KASP-SNP | R04006069830 | R04006069877 | R04006069900 | 0.556 | |||||
| mutant | G | G | G | 31.08 | 8 | ||||||||
| wt | G | A | A | 55.78 | 9 | ||||||||
| F-box 118 | 0.01** | 30.9 | 3 | KASP-SNP | R04006263057 | R04006263087 | R04006263168 | 0.581 | |||||
| mutant | G | T | G | 33.707 | 4 | ||||||||
| wt | C | A | C | 57.999 | 12 | ||||||||
| F-box 119 | 0.005** | 40.4 | 3 | KASP-SNP | R04006388017 | R04006388095 | 0.506 | ||||||
| mutant | A | C | 29.332 | 5 | |||||||||
| wt | C | G | 57.999 | 12 | |||||||||
| LR10 | 0.046* | 26.7 | 2 | KASP-SNP | R04006451404 | R04006451424 | R04006451469 | R04006451485 | R04006451495 | 0.602 | |||
| mutant | C | A | A | G | G | 34.63 | 9 | ||||||
| wt | T | C | G | A | T | 57.54 | 11 | ||||||
| OsSTPS2 | 0.006** | 38.6 | 2 | KASP-SNP | OsSTPS2_SNP1 | OsSTPS2_SNP2 | OsSTPS2_SNP3 | OsSTPS2_21bp_indel | 0.604 | ||||
| mutant | G | T | C | Insertion | 36.25 | 12 | |||||||
| wt | G | T | C | deletion | 60 | 6 | |||||||
| Verticillium wilt resistance protein | 0.020* | 19.6 | 2 | KASP-SNP | R04016672214 | 0.688 | |||||||
| mutant | T | 42.764 | 17 | ||||||||||
| wt | G | 62.112 | 6 | ||||||||||
| BPH9_Chr12 | < 0.001** | 71 | 2 | KASP-SNP | R1222886067 | R1222886105 | 0.254 | ||||||
| mutant | G | T | 14.667 | 3 | |||||||||
| wt | A | G | 57.667 | 13 | |||||||||
| UBN | BPH9_Chr12 | < 0.001** | 83.3 | 2 | KASP-SNP | R1222886067 | R1222886105 | 0.464 | |||||
| mutant | G | T | 28.5 | 3 | |||||||||
| wt | A | G | 61.411 | 13 | |||||||||
*Significant at P = 0.05
**Significant at P = 0.001
HP analysis of significant genes in mutant lines. Number 1 to 10 represented HP number of each gene by which HP number 1 was specific to WT (Additional file 1: Table S6). R = resistance, MR = moderately resistance, S = susceptible
| KASP marker name | inorganic phosphate transporter | gamma thionin protein | F-box 118 | F-box 119 | LR10 | OsLecRK1 | OsLecRK2 | OsLecRK3 | OsSTPS2 | Verticillium wilt resistance protein | BPH32 | BPH9 | BPH -CNT | BPH -TPY | BPH- UBN |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RH | 1 | 2 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 1 | 2 | 1 | R | R | R |
| JHN | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | S | S | S |
| JHN4 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | R | R | R |
| JHN12005 | 1 | 2 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 1 | 3 | R | R | MR |
| JHN19525 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 2 | MR | R | MR |
| JHN09962 | 1 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | S | R | R |
| JHN19874 | 1 | 3 | 2 | 2 | 3 | – | – | 3 | 2 | 2 | 1 | 4 | S | S | S |
| JHN07766 | 1 | 2 | 2 | 4 | 2 | 3 | 4 | 2 | 2 | 2 | 1 | 1 | S | S | S |
| JHNMT2 | 1 | 1 | 1 | 1 | 1 | 4 | 5 | 4 | 2 | 2 | 1 | 3 | S | S | S |
| JHN11183 | 2 | 1 | 2 | 4 | 4 | 5 | 6 | 5 | 1 | 2 | 1 | 3 | S | S | MR |
| JHNMT1 | 1 | 1 | 1 | 1 | 1 | 4 | 5 | 4 | 2 | 2 | 1 | 3 | S | S | S |
| JHN05678 | 1 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | S | S | S |
| JHN19572 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | S | S | S |
| JHN21689 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 6 | 1 | 1 | 1 | 1 | S | S | S |
| JHN16065 | 2 | 4 | 1 | 1 | 1 | 1 | 1 | 7 | 3 | 2 | 1 | 1 | S | S | S |
| JHN02313 | 2 | 1 | 1 | 1 | 1 | 6 | 7 | 8 | 4 | 1 | 1 | 1 | S | S | S |
| JHN15723 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | S | S | S |
| JHN18131 | 2 | 5 | 1 | 1 | 1 | 1 | 1 | 9 | 4 | 2 | 1 | 4 | S | S | S |
| JHN19671 | 2 | 4 | 1 | 1 | 1 | 1 | 1 | 9 | 3 | 2 | 1 | 1 | S | S | S |
| JHN12686 | 1 | 1 | 1 | 1 | 5 | – | 8 | 1 | 1 | 1 | 1 | 4 | S | S | S |
| JHN17767 | 2 | 4 | 1 | 1 | 1 | – | 1 | 9 | 4 | 2 | 1 | 1 | S | S | S |
| JHN19577 | 1 | 3 | 2 | 4 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | S | S | S |
| JHN19578 | 1 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | S | S | S |
| JHN21688 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 10 | 1 | 1 | 1 | 1 | S | S | S |
HP analysis of significant genes in 5 extreme resistant-BILs and five extreme susceptible-BILs. Number 1 to 4 represented HP numbers of each gene by which HP number 1 was specific to JHN WT (Additional file 1: Table S6). Six BPH local populations including KPP, NAN, PSL, UBN, TPY, and HTL were used for BPH damage AUC test. - = missing data
| BIL no. | inorganic phosphate transporter | gamma thionin protein | F-box 118 | F-box 119 | LR10 | OsLecRK1 | OsLecRK2 | OsLecRK3 | OsSTPS2 | Verticillium wilt resistance protein | BPH32 | BPH9 | BPH damage AUC | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KPP | NAN | PSL | UBN | TPY | HTL | Average | BPH resistance | |||||||||||||
| RH | 1 | 2 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 1 | 2 | 1 | 12.3 | 17.3 | 10.3 | 9.7 | 9.7 | 8.3 | 11.3 | R |
| UBN03078–101–342-4-147 | 1 | – | – | 3 | 2 | 2 | 3 | 2 | 2 | 1 | 2 | 1 | 12 | 12 | 14.3 | 9.3 | 14.7 | 21 | 13.9 | R |
| 423(4) | 2 | 4 | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 2 | 2 | 1 | 11.7 | 16.7 | 13.7 | 11 | 16 | 18.3 | 14.6 | R |
| UBN03078–101–342-4-20 | 1 | 2 | 3 | – | – | 2 | 3 | 2 | 2 | – | 2 | 1 | 12 | 23 | 12.3 | 12 | 14.3 | 14.3 | 14.7 | R |
| UBN03078–101–342-4-138 | – | 2 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 1 | 2 | 1 | 12.3 | 21 | 15.3 | 15.7 | 15.3 | 10 | 14.9 | R |
| UBN03078–101–342-4-24 | 1 | 2 | 3 | 3 | – | 2 | 3 | 2 | 2 | 1 | 2 | 1 | 12 | 15.3 | 16.7 | 12 | 14.7 | 19.3 | 15 | R |
| UBN03078–81–504-1 | – | – | 3 | 1 | 2 | 2 | 1 | 1 | H | 1 | 2 | 1 | 25.3 | 35.7 | 36 | 32.7 | 26.7 | 34.3 | 31.8 | S |
| UBN03078–80–354-7 | 1 | – | – | – | – | 2 | 1 | 1 | 1 | 1 | 2 | – | 29.7 | 31 | 31.7 | 35.7 | 30 | 31.3 | 31.6 | S |
| UBN03078–80–354-7 | 1 | – | – | 1 | – | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 35.7 | 30.3 | 32 | 32 | 22 | 35.7 | 31.3 | S |
| UBN03078–101–450-1 | 1 | – | 3 | 1 | – | 2 | 1 | 1 | 1 | 1 | 2 | 1 | 25.7 | 33.7 | 27.3 | 28.7 | 29 | 33 | 29.6 | S |
| UBN03078–80–28-5 | 1 | 2 | 3 | 1 | 2 | 2 | 1 | 1 | H | 1 | 2 | 1 | 19 | 36 | 36 | 29 | 25.3 | 28 | 28.9 | S |
| KDML105 | 2 | 4 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 34 | 36 | 36 | 35.3 | 30.3 | 36 | 34.6 | S |
Fig. 4Phylogenetic analysis of the mutant lines, JHN-WT, KDML105, RH, BILs, and other germplasm rice accessions. The evolutionary history was inferred using the UPGMA method
Fig. 5Graphical genotype analysis of 15 Mb spanned QBPH4.1 genomic region. a The extreme resistant BILs were analyzed with KDML105 and RH, b The JHN mutant lines were analyzed with JHN-WT and RH, c Haplotype patterns at seven novels amino acids of mutant lines. SNPs at position 6,956,325 and 6,956,441 were developed as the KASP markers for HP analysis. Filled squares represented gene-specific SNPs, filled arrowheads represented intergenic SNPs, and asterisks represented the recombination breakpoint